Advertisement

Topics

#Biopharma Stock News: Otonomy (NASDAQ: $OTIC) Third Quarter 2017 Financial Results and Corporate Update

01:00 EST 9 Nov 2017 | InvestorIdeas

SAN DIEGO - November 9, 2017 (Investorideas.com Newswire) Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, reported financial results for the quarter ended September 30, 2017 and provided an update on its corporate activities and product pipeline.

Original Article: #Biopharma Stock News: Otonomy (NASDAQ: $OTIC) Third Quarter 2017 Financial Results and Corporate Update

NEXT ARTICLE

More From BioPortfolio on "#Biopharma Stock News: Otonomy (NASDAQ: $OTIC) Third Quarter 2017 Financial Results and Corporate Update"

Advertisement
Quick Search
Advertisement
Advertisement